|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.315 EUR | 0.00% |
|
+2.73% | -20.54% |
| Mar. 18 | Ulisse Biomed, subsidiary sign distribution agreement with Mediline | AN |
| Mar. 05 | Europe's only Mib in green; Webuild bullish | AN |
Ulisse Biomed S.p.A. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was EUR 0.016139 million compared to EUR 0.063669 million a year ago. Revenue was EUR 0.087876 million compared to EUR 0.311819 million a year ago.
Net loss was EUR 0.899562 million compared to EUR 0.531597 million a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -20.54% | 30.28M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
ULISSE BIOMED S.P.A. 
